Although the initial Hb level in the improved anemia group was approximately 9g/dL, an increasing trend in Hb level reflected good response to treatment and resulted in better 10-year survival, compared with the persistent anemia group.
← all excerpts
Hemoglobin level trajectories in the early treatment period are related with survival outcomes in patients with breast cancer.
1
—
—